LeafSource Nigella
LeafSource Nigella, licence 80084962: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- LeafSource Nigella Sativa, Nigella Sativa
- Licence holder
- Ever Organics
- NPN or DIN-HM
- 80084962
- Status
- Active licence
- Licence date
- 7 May 2018
- Revision date
- 16 October 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acides humiques Source : Tourbe | 125.0 mg | Not calculated |
| Nigella sativa Source : Graine(s) | 500.0 mg | Not calculated |
| Potassium Source : Chlorure de potassium | 1.25 mg | 5,000 µg |
| Phosphore Source : Acide phosphorique | 0.5 mg | 2,000 µg |
Non-medicinal ingredients
Poudre d'Oryza Sativa (Riz), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Mineral supplement.Source of potassium, a factor/factors in the maintenance of good health. Source of potassium, a factor/factors in normal growth and development. Source of potassium and phosphorus to support biological functions which play a key role in the maintenance of good health. Helps to temporarily support glucose metabolism.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Consult a heath care practitioner prior to use if you have diabetes or hypercholesterolemia. If you have a liver or immune system disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80084962
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.